Last updated on May 2018

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)


Brief description of study

The purpose of this study is to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in prolonging progression free survival (PFS) in patients with relapsed iNHL who have received one or more lines of treatment, including rituximab and who either had a treatment-free interval of 12 months after completion of the last rituximab-containing treatment, or who are unwilling to receive chemotherapy/for whom chemotherapy is contraindicated on reason of age, comorbidities, and/or residual toxicity.

Clinical Study Identifier: NCT02367040

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Louisville, KY United States
  Connect »

Bayer Clinical Trials Contact

Goldsboro, NC United States
  Connect »

Bayer Clinical Trials Contact

Cleveland, OH United States
  Connect »

Bayer Clinical Trials Contact

Allentown, PA United States
  Connect »

Bayer Clinical Trials Contact

Watertown, SD United States
  Connect »

Bayer Clinical Trials Contact

Salt Lake City, UT United States
  Connect »

Bayer Clinical Trials Contact

Ciudad Auton. de Buenos Aires, Argentina
  Connect »

Bayer Clinical Trials Contact

Landeskrankenhaus Rankweil
Rankweil, Austria
  Connect »

Bayer Clinical Trials Contact

Bruxelles - Brussel, Belgium
  Connect »

Bayer Clinical Trials Contact

Vandoeuvre-les-nancy, France
  Connect »

Bayer Clinical Trials Contact

Jeollanam-do, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

Seoul National University Hospital
Seoul, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

Asan Medical Center
Seoul, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

Esch-sur-alzette, Luxembourg
  Connect »

Bayer Clinical Trials Contact

Vila Nova de Gaia, Portugal
  Connect »

Bayer Clinical Trials Contact

Chelyabinsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Irkutsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Kemerovo, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Krasnoyarsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Novosibirsk, Russian Federation
  Connect »

Bayer Clinical Trials Contact

St. Petersburg, Russian Federation
  Connect »

Bayer Clinical Trials Contact

Volgograd, Russian Federation
  Connect »

Bayer Clinical Trials Contact

West Covina, CA United States
  Connect »

Bayer Clinical Trials Contact

Farmington Hills, MI United States
  Connect »

Bayer Clinical Trials Contact

Las Vegas, NV United States
  Connect »

Bayer Clinical Trials Contact

Englewood, NJ United States
  Connect »